HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rajiv Bassi Selected Research

IMC-EB10

2/2005Inhibitory anti-FLT3 antibodies are capable of mediating antibody-dependent cell-mediated cytotoxicity and reducing engraftment of acute myelogenous leukemia blasts in nonobese diabetic/severe combined immunodeficient mice.
8/2004Suppression of leukemia expressing wild-type or ITD-mutant FLT3 receptor by a fully human anti-FLT3 neutralizing antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rajiv Bassi Research Topics

Disease

22Neoplasms (Cancer)
03/2012 - 05/2002
5Neoplasm Metastasis (Metastasis)
02/2010 - 06/2002
4Colorectal Neoplasms (Colorectal Cancer)
06/2011 - 05/2002
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2012 - 03/2007
3Pathologic Neovascularization
11/2006 - 05/2002
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2005 - 08/2004
2Carcinoma (Carcinomatosis)
01/2009 - 05/2002
2Melanoma (Melanoma, Malignant)
09/2008 - 01/2007
2Carcinogenesis
06/2007 - 05/2005
2Breast Neoplasms (Breast Cancer)
11/2006 - 12/2003
2Leukemia
09/2004 - 08/2004
1Lung Neoplasms (Lung Cancer)
10/2007
1Pancreatic Neoplasms (Pancreatic Cancer)
09/2006
1Adenocarcinoma
06/2004
1Chromosomal Instability (Chromosome Stability)
06/2004

Drug/Important Bio-Agent (IBA)

9ErbB Receptors (EGF Receptor)IBA
03/2012 - 05/2002
8Cetuximab (Erbitux)FDA Link
06/2011 - 05/2002
8Monoclonal AntibodiesIBA
01/2009 - 05/2002
7AntibodiesIBA
03/2012 - 01/2004
5Immunoglobulin G (IgG)IBA
03/2012 - 08/2004
5Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
06/2009 - 06/2002
4LigandsIBA
06/2009 - 12/2003
4Mitogen-Activated Protein KinasesIBA
12/2007 - 12/2003
3Irinotecan (Camptosar)FDA LinkGeneric
06/2011 - 05/2002
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2009 - 06/2002
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2005 - 06/2002
2DNA (Deoxyribonucleic Acid)IBA
03/2012 - 06/2011
2PlatinumIBA
03/2012 - 12/2007
2Phosphotransferases (Kinase)IBA
02/2010 - 10/2007
2Neutralizing AntibodiesIBA
02/2010 - 08/2004
2Cytotoxins (Cytolysins)IBA
02/2010 - 11/2006
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
06/2009 - 03/2005
2Proteins (Proteins, Gene)FDA Link
06/2009 - 01/2007
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2008 - 06/2002
2IMC-EB10IBA
02/2005 - 08/2004
1MethyltransferasesIBA
03/2012
1human MIRN29B1 microRNAIBA
03/2012
1GemcitabineFDA Link
03/2012
1Pemetrexed (MTA)FDA Link
03/2012
1Cisplatin (Platino)FDA LinkGeneric
03/2012
1necitumumabIBA
03/2012
1Paclitaxel (Taxol)FDA LinkGeneric
03/2012
1Pharmaceutical PreparationsIBA
06/2011
1Biomarkers (Surrogate Marker)IBA
06/2011
1CytokinesIBA
02/2010
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2010
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
02/2010
1Transforming Growth Factor beta (TGF-beta)IBA
02/2010
1Angiogenesis InhibitorsIBA
06/2009
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
06/2009
1Trastuzumab (Herceptin)FDA Link
01/2009
1Differentiation AntigensIBA
09/2008
1DC101 monoclonal antibodyIBA
09/2008
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2007
1DNA AdductsIBA
12/2007
1Mitogen-Activated Protein Kinase 3IBA
12/2007
1Becaplermin (PDGF-BB)FDA Link
06/2007
1Platelet-Derived Growth FactorIBA
06/2007
1Docetaxel (Taxotere)FDA Link
03/2007
1Monophenol Monooxygenase (Tyrosinase)IBA
01/2007
1AntigensIBA
01/2007
1Fc Receptors (Fc Receptor)IBA
01/2007
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
11/2006
1IMC-18F1IBA
11/2006
1Biological ProductsIBA
05/2005
1Somatomedin Receptors (Somatomedin Receptor)IBA
05/2005
1Epidermal Growth Factor (EGF)IBA
05/2005
1Bispecific AntibodiesIBA
05/2005
1Platelet-Derived Growth Factor alpha ReceptorIBA
03/2005
1Interleukin-6 (Interleukin 6)IBA
09/2004
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2004
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2004
1ImmunosorbentsIBA
08/2004
1EnzymesIBA
08/2004
1fms-Like Tyrosine Kinase 3IBA
08/2004
1Immunoglobulins (Immunoglobulin)IBA
08/2004
1Messenger RNA (mRNA)IBA
06/2004
1Leucine (L-Leucine)FDA Link
06/2004
1Complementary DNA (cDNA)IBA
06/2004
1N- (2,6- dimethylphenyl)- 4- (((diethylamino)acetyl)amino)benzamideIBA
06/2004
1Cell Surface ReceptorsIBA
12/2003
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
12/2003
1Insulin-Like PeptidesIBA
12/2003
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
12/2003
1AlginatesIBA
06/2002
1Bromodeoxyuridine (BrdU)IBA
05/2002
1cadherin 5IBA
05/2002
1E4G10 antibodyIBA
05/2002
1EpitopesIBA
05/2002
1Topoisomerase I InhibitorsIBA
05/2002

Therapy/Procedure

5Therapeutics
06/2011 - 05/2002
4Drug Therapy (Chemotherapy)
03/2012 - 03/2007
1Immunotherapy
09/2008
1Injections
02/2005